Packaging Simulation Answers the Need for Speed

Pseudo-empirical modeling of drug packaging conditions can save up to six months in getting pharmaceuticals to market.

By Adrian Possumato, Global Manager - Pharmaceutical Market, Multisorb Technologies

1 of 2 < 1 | 2 View on one page

For pharmaceutical companies, time really is money: those who get to market first with a new product will often capture the largest customer share and maximize profits. Drug innovators commit considerable resources to developing and seeking approval for breakthrough products, because the sooner they can market a new product, the sooner they can begin to see returns on their investment.

Time is of the essence for manufacturers of generic drugs, too, since they often have a suite of drug applications pending and they vie with competitors to be the first to commercialize their products for the 180-day period of marketing exclusivity. For these reasons, technologies and services that streamline drug development can provide important competitive advantages to drug manufacturers.

Sophisticated packaging simulation modeling can help formulation chemists and packaging engineers identify the right conditions for ensuring the chemical and physical stability of drugs. The simulations are referred to as ‘pseudo-empirical’ modeling and can be performed early in the development process, guiding production decisions and helping to avoid costly errors that could prove to be roadblocks to production.

Pseudo-empirical modeling is a technique that uses empirically derived data from the packaging materials, including moisture vapor transmission rate (MVTR) through the bottle, surface area of the bottle, sorbent adsorption isotherms and drug product adsorption/desorption isotherms. Linking these variables together mathematically will pseudo-empirically predict the relative humidity of a pharmaceutical package’s headspace and drug product hydration level over time.

This resulting information will ultimately determine the means by which manufacturers can maintain a drug’s chemical and physical characteristics throughout its shelf life.

Customized Moisture Management

Pharmaceuticals can be subject to chemical and physical degradation through interaction with moisture. This is because free moisture increases the molecular mobility within drug product formulations that can directly affect the rate of all chemical degradation pathways.

Desiccants are used to reduce free moisture within the drug product and thereby curb molecular mobility while reducing the potential for further hydration from moisture ingress through its primary packaging. There are a wide range of desiccants available to maintain pharmaceutical integrity, but it is important to choose the right desiccant type, amount and format for each drug product. Determining the best combination requires a precise analysis that takes into account the drug characteristics and packaging materials as well as the sorbent’s functionality.

Pseudo-empirical modeling can be especially helpful because engineers first define the adsorption properties of a particular drug product and then simulate the effect of that formulation in combination with a given packaging presentation with varying amounts and types of desiccants. This approach takes into account conditions during all stages of drug processing, from formulation to the packaging environment and throughout distribution.

After running this analysis, engineers can provide specifications for the best product/packaging combinations. Simulations can be performed for many types of pharmaceutical packaging in accordance with the guidelines for stability testing set by the International Conference on Harmonization for accelerated test conditions (six months at 40°C and 75% relative humidity (RH)) or real-time (room temperature) test conditions (two years, typically at 25°C and 60% RH).

Simulations at either condition require specific input criteria (e.g., isotherms, MVTR, etc.) to account for the effect that temperature has on polymers and drug products. Because of the ability to perform testing under accelerated conditions, simulations can help drug makers find a stability solution quickly, reducing sorbent ranging studies and testing time by at least six months, thus speeding regulatory filings, subsequent approvals, product launches and ultimately cash flow. It can also result in cost savings, as it enables manufacturers to purchase the precise amount of sorbent they will need for a given drug product’s packaging requirements.

Finding the Right Combination

Today’s sorbents are often described as “active packaging components” because they respond to changes in the headspace of packaging relative to outside conditions. The goals of stability testing for drug packages are: 1) to determine what the internal conditions of a drug package will be under given conditions, and 2) to predict equilibrium relative humidity (ERH) and drug product hydration over the course of the product’s shelf life.

The calculations take into account the humidity levels both inside and outside the package, as well as the drug’s and desiccant’s respective affinities for moisture at varying humidity and/or temperature levels and the rate of transfer of moisture and vapor through the package wall.

In essence, the modeling approach simulates how the interdependent variables — drug, desiccant and package — will affect one another over time. With this information, it is possible for drug makers to ensure the stability of their formulations and set appropriate expectations for their shelf lives. For example, a simulation of a solid drug packaged in a high-density polyethylene bottle and subject to moisture degradation would take into account three interdependent parameters: the moisture vapor transmission rate through the bottle wall; the adsorption isotherm for the drug (Figure 1), and finally, the adsorption isotherm for the desiccant (also in Figure 1).

Figure 1 shows the adsorption isotherms for a drug product (light blue line), a molecular sieve desiccant (red line) and a silica gel desiccant (dark blue line).

1 of 2 < 1 | 2 View on one page
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments